GlaxoSmithKline PLC to Discuss About Investing in Healthcare Innovations: A Case Study of Multi-stakelholder Capitalism in Practice Call Transcript
Good morning, good afternoon and good evening, depending on where you're joining us from. I'm Ariel Babcock, FCLT Global's Head of Research. We're a nonprofit whose mission is to reorient capital markets to focus capital on the long term in support of a more prosperous sustainable economy.
We've got a terrific group assembled here for today's conversation to take a topic that's really important and timely into discussion. So our goal is to spend the time together in interactive dialogue. This is something that we do at FCLT on a regular basis. We bring together leading asset owners, asset managers and companies to develop practical solutions that market participants can use to make long-term practices the norm and not the exception. So how do you make the long-term decision the default instead of the difficult is something that we grapple with every day.
Today, we're going to talk about the financing of health care advancements and particularly vaccine development. This became a central priority of our time with the onset of the COVID-19 pandemic, but the scale and importance of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
